Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)
$16.90
0.29 (1.75%)
TEVA Stock Quote Delayed 30 Minutes
5 Top Stock Trades for Wednesday: GILD, NVDA, AMD
Nvidia, American Airlines, Teva, AMD and Gilead Sciences are our top stock trades to watch for Wednesday. See the charts here.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
18.76B
PE Ratio
-11.66
EPS
-1.45
Volume (Avg. Vol.)
287,819
Day's Range
$16.80 - $16.93
52-Week Range
$12.51 - $22.80
Dividend & Yield
N/A (N/A)
TEVA Stock Predictions, Articles, and Teva Pharmaceutical Industries Limited American Depositary Shares News
BMO’s Got A Point About Teva Stock, But Are Investors Willing To Listen?
Teva stock is only getting lukewarm love from analysts, but tacitly, these pros may be more optimistic than they're letting on.
After Berkshire Bought Teva Pharmaceutical Stock, Should Others Follow Suit?
TEVA stock has multiple headwinds, including high debt and weakeneing Copaxone sales. But TEVA should benefit from promising new products.
Teva Pharmaceutical Earnings: Why TEVA Stock Is Tanking Today
Teva Pharmaceutical earnings for the fourth quarter of 2018 has TEVA stock falling hard on Wednesday with an EPS miss for the period.
Wednesday’s Vital Data: Netflix, Qualcomm and Micron
Options trading was buzzing in Netflix, Micron, and Qualcomm. Here are the metrics and levels that matter moving forward.
Value Investors Should Buy into the Teva Stock Dip
Teva stock is now at yearly lows, a victim of negative macro news, falling stock markets, and year-end tax-loss selling.
Should Warren Buffett — And You — Buy More TEVA Stock Right Now?
Teva's turnaround is working, but a serious worry is now hitting shares. Should you be buying more TEVA stock with this looming danger?
6 Pharmaceutical Stocks to Buy After the Midterms
The upside case for pharmaceutical stocks is building. The midterm elections results mean its unlikely drug price regulation will happen soon.
Even Following the Latest Surge, Mylan Stock Has Plenty of Room to Grow
Mylan stock jumped ahead following quarterly earnings that impressed investors. Management will continue doing better than expected.
Teva Wins Approval From FDA for Blockbuster Migraine Drug
The markets are ignoring the potential sales growth for Teva's migraine drug. Value investors should look at Teva stock now.
5 Top Stock Trades for Tuesday — Trading Oracle, FedEx Earnings
FedEx and Oracle are set to report earnings, while JD and Teva were in the news as we manage our top stock trades heading into Tuesday. Here's what you need to know.
Why Teva’s Outlook Is Mixed
TEVA stock is on a comeback rally after suffering two years of horrific losses, but its outlook is mixed.
EpiPen Shortage 2018: 13 Things for Parents to Know
An EpiPen shortage has parents worried as the school season starts back up across the U.S., but there are other options.
5 Top Stock Trades for Friday Morning — Trading Nvidia Earnings
Here are the trading levels to keep in mind for Nvidia. Walmart, J.C. Penney and JD.com all post huge moves after reporting their quarterly results. Here are our top stock trades for Friday.
Why Teva Pharmaceutical Stock Is Sinking Today
Teva Pharmaceutical (TEVA) stock was down on Thursday following the release of its earnings report for the second quarter of 2018.
